Showing results (11-20 of 336) with videos related to
Sort By:
Pageof 34
Blood|November 10, 2020
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of careHanny Al-SamkariBlood Reviews|November 1, 2023
Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonistsHanny Al-SamkariResearch and Practice in Thrombosis and Haemostasis|September 2, 2025
Should thrombopoietin receptor agonists be used for chemotherapy-induced thrombocytopenia?Hanny Al-SamkariPediatric Blood & Cancer|November 14, 2024
Mitapivat for Acquired Pyruvate Kinase DeficiencyHanny Al-SamkariAmerican Journal of Hematology|August 6, 2024
2025 update on clinical trials in immune thrombocytopeniaHanny Al-SamkariHaematologica|June 6, 2020
A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignanciesHanny Al-Samkari, Aric D Parnes, Katayoon Goodarzi, et al.Journal of Thrombosis and Haemostasis : JTH|April 30, 2021
Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancyNathan Watson, Hanny Al-SamkariActa Haematologica|July 24, 2020
An Eltrombopag Red (Plasma) AlertHanny Al-Samkari, Katayoon GoodarziAnnual Review of Pathology|September 22, 2017
Hemophagocytic LymphohistiocytosisHanny Al-Samkari, Nancy BerlinerDrugs of Today (Barcelona, Spain : 1998)|March 11, 2022
Eptacog beta, a novel recombinant factor VIIa, for the treatment of hemophiliaNathan Watson, Hanny Al-SamkariPageof 34